Sign up Australia
Proactive Investors - Run By Investors For Investors

The Hydroponics Company enters licencing agreement with Canadian leader

Shares have rallied 15% intra-day, currently priced at $0.85.
concept for medical cannabis
To date, NAC has helped more than 10,000 Canadian medicinal cannabis patients

The Hydroponics Company Ltd (ASX:THC) has reached a licensing agreement with National Access Cannabis (NAC) of Canada.

The agreement gives THC immediate access to NAC’s intellectual property that will assist in the development of a professional clinic model, offering THC a unique path to market in Australia.

NAC is Canada’s best practices leader in delivering secure, safe, and responsible access to legal medicinal cannabis.

It provides high-quality physician and patient support and training in professional patient-friendly clinics environments.

THC will use the Canadian clinical model to create a solution in Australia

David Radford, chief executive, said: “Having visited their medical clinic in Ottawa, I believe that the quality processes and care that they have developed for their patients has a real and exciting place in the Australian marketplace.

“We will be working with the State Governments and Physicians to rapidly integrate this unique, quality assured program for the betterment of the Australian patients.

READ: The Hydroponics Company in company making partnership with Israel's BOL Pharma

“We look forward to working with the NAC team and leveraging their clinical model to provide a local healthcare solution which will facilitate patient access to a broad range of high, quality, legal medicinal cannabis products in Australia and New Zealand.

“Our expansion into the development of medicinal cannabis clinics will allow THC to work with local cannabis companies as they seek to develop a path to market.”

10-year licence in Australia and New Zealand with Asia option

The agreement provides for a transfer of technology, knowledge and intellectual property for 10 years in Australia and New Zealand, with a further option to extend by 10 years.

It also provides for a first right of refusal option to develop into Asia as the market matures.

THC is able to leverage NAC’s extensive relationships with Canadian licenced producers and access to new medicinal products.

THC will pay NAC a licensing fee of $500,000 upon or before the second anniversary of the agreement or successfully achieving an initial gross revenue milestone of $1 million, whichever occurs first.

Thereafter, THC will pay NAC ongoing quarterly royalties equivalent to 7.5% of gross revenue.

Join our Crypto, Blockchain and Cannabis Telegram group here
View full THC profile View Profile

The Hydroponics Company Ltd Timeline

Related Articles

1539364967_Cannabis-plant.jpg
October 10 2018
Management behind ICC International Cannabis Corp has a clear buy, build and sell strategy
Laboratory testing
October 10 2018
Fifteen patients have been enrolled in the trial being carried out at Children’s Hospital of Philadelphia in the USA.
Woman holding cannabis leaf
October 16 2018
Canadian subsidiary Crystal Mountain is expanding its range of hydroponics equipment to meet expected demand.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use